Lv61
1625 积分 2021-12-23 加入
Chimeric antigen receptor-modified macrophages ameliorate liver fibrosis in preclinical models
20天前
已完结
Obesity and Insulin Resistance: Associations with Chronic Inflammation, Genetic and Epigenetic Factors
25天前
已完结
New and emerging treatments for metabolic dysfunction-associated steatohepatitis
1个月前
已完结
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
1个月前
已完结
抗缪勒管激素测定试剂盒(化学发光免疫分析法)
3个月前
已完结
酶联免疫试剂盒检测通则
4个月前
已完结
An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH
6个月前
已完结
Resmetirom: First Approval
6个月前
已完结
Resmetirom's approval: Highlighting the need for comprehensive approaches in NASH therapeutics
6个月前
已完结
绿原酸的研究进展
8个月前
已完结
皖公网安备34019202002308
